Little is known about the factors that influence clearance of human papillomavirus (HPV), the
primary cause of cervical carcinoma. A total of 227 women cytologically normal and HPV …

Cervical cancer is one of the most common neoplastic diseases affecting women, with a
combined worldwide incidence of almost half a million new cases annually, second only to …

Given the fact that infection with high‐risk human papillomavirus (HPV) is causally involved
in cervical cancer, addition of high‐risk HPV testing to a cervical smear may improve the …

Persistent high-risk human papillomavirus (HR-HPV) infections play a major role in the
development of invasive cervical cancer (CC), and screening for such infections is in many …

Testing for human papillomavirus (HPV) relies exclusively on techniques of molecular
biology using nucleic acid probes. Tests for HPV using nucleic acid probes have been …

Currently, human papillomavirus (HPV) DNA tests validated in large trials and
epidemiological studies are the hybrid capture second-generation (HC2) HPV DNA assay …

Understanding the interdependent roles that host and viral factors play in cervical cancer
pathogenesis is important for distinguishing women at the highest risk of human …

El cáncer del cuello uterino es una de las neoplasias malignas de mayor incidencia y
mortalidad entre las mujeres de todas partes del mundo, hallazgo que resulta paradójico si …

Our objective was to review current large studies of human papillomavirus (HPV) DNA
testing as an adjunct to the Papanicolaou test for cervical cancer screening programs. We …

High loads of human papillomavirus (HPV) 16 and HPV 18/45 increase the risk of
developing invasive cervical carcinoma, revealing higher risk in percentiles of highest viral …